Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

K Nogami, Y Maruyama… - Human molecular …, 2021 - academic.oup.com
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by
progressive muscular weakness because of the loss of dystrophin. Extracellular Ca2+ flows …
被引用次数：35 相关文章

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

KI Nogami, Y Maruyama… - Human Molecular …, 2021 - waseda.elsevierpure.com
抄録 Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by
progressive muscular weakness because of the loss of dystrophin. Extracellular Ca2+ flows …

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

K Nogami, Y Maruyama, F Sakai-Takemura… - Human Molecular …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Duchenne muscular dystrophy (DMD) is an X-
linked genetic disorder characterized by progressive muscular weakness because of the …

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice.

K Nogami, Y Maruyama… - Human Molecular …, 2021 - search.ebscohost.com
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by
progressive muscular weakness because of the loss of dystrophin. Extracellular Ca< sup> …
[PDF] oup.com

[PDF][PDF] Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

K Nogami, Y Maruyama… - Human Molecular …, 2021 - academic.oup.com
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by
progressive muscular weakness because of the loss of dystrophin. Extracellular Ca2+ flows …

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

K Nogami, Y Maruyama… - Human molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by
progressive muscular weakness because of the loss of dystrophin. Extracellular Ca2+ flows …

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice.

K Nogami, Y Maruyama, F Sakai-Takemura… - Human Molecular …, 2021 - europepmc.org
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by
progressive muscular weakness because of the loss of dystrophin. Extracellular Ca 2+ flows …
[HTML] nih.gov

[HTML][HTML] Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

K Nogami, Y Maruyama, F Sakai-Takemura… - Human Molecular …, 2021 - ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by
progressive muscular weakness because of the loss of dystrophin. Extracellular Ca 2+ flows …

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

KI Nogami, Y Maruyama… - Human Molecular …, 2021 - waseda.elsevierpure.com
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder characterized by
progressive muscular weakness because of the loss of dystrophin. Extracellular Ca2+ flows …